Home
>
US Stocks
>
National Healthcare Corporation

National Healthcare Corporation (NHC)

$61.72

-1.26

(-2%)▲

Market is closed - opens 7 PM, 12 Jun 2023

Insights on National Healthcare Corporation

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 218.84M → 269.56M (in $), with an average increase of 18.8% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -2.42M → 11.72M (in $), with an average increase of 92.0% per quarter

  • Vs HCA

    In the last 1 year, Hca Holdings, Inc. has given 38.2% return, outperforming this stock by 48.5%

  • Vs HCA

    In the last 3 years, Hca Holdings, Inc. has given 146.9% return, outperforming this stock by 154.4%

Performance

  • $61.72
    $62.77
    $61.72
    downward going graph

    0.0%

    Downside

    Day's Volatility :1.67%

    Upside

    1.67%

    downward going graph
  • $51.04
    $70.24
    $61.72
    downward going graph

    17.3%

    Downside

    52 Weeks Volatility :27.33%

    Upside

    12.13%

    downward going graph

Returns

PeriodNational Healthcare CorporationSector (Health Care)Index (Russel 2000)
3 Months
16.41%
5.1%
-0.2%
6 Months
4.57%
-5.5%
-1.5%
1 Year
-10.26%
3.9%
-1.7%
3 Years
-7.48%
27.0%
20.6%

Highlights

Market Capitalization
945.6M
Book Value
$57.25
Dividend Share
2.28
Dividend Yield
3.73%
Earnings Per Share (EPS)
1.22
PE Ratio
50.59
PEG Ratio
0.0
Wall Street Target Price
6.15
Profit Margin
1.75%
Operating Margin TTM
2.2%
Return On Assets TTM
1.13%
Return On Equity TTM
1.78%
Revenue TTM
1.1B
Revenue Per Share TTM
69.88
Quarterly Revenue Growth YOY
0.4%
Gross Profit TTM
388.1M
EBITDA
64.4M
Diluted Eps TTM
1.22
Quarterly Earnings Growth YOY
-0.23
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Analyst Forecast

What analysts predicted

Downside of 90.04%

Current $61.72
Target $6.15

Company Financials

FY17Y/Y Change
Revenue
967.0M
↑ 4.36%
Net Income
56.2M
↑ 11.21%
Net Profit Margin
5.81%
↑ 0.36%
FY18Y/Y Change
Revenue
980.3M
↑ 1.38%
Net Income
59.0M
↑ 4.91%
Net Profit Margin
6.01%
↑ 0.2%
FY19Y/Y Change
Revenue
996.4M
↑ 1.64%
Net Income
68.2M
↑ 15.68%
Net Profit Margin
6.85%
↑ 0.84%
FY20Y/Y Change
Revenue
980.7M
↓ 1.57%
Net Income
41.9M
↓ 38.62%
Net Profit Margin
4.27%
↓ 2.58%
FY21Y/Y Change
Revenue
1.0B
↑ 3.08%
Net Income
138.6M
↑ 230.99%
Net Profit Margin
13.71%
↑ 9.44%
FY22Y/Y Change
Revenue
1.0B
↑ 1.79%
Net Income
22.4M
↓ 83.8%
Net Profit Margin
2.18%
↓ 11.53%
Q4 FY21Q/Q Change
Revenue
268.4M
↑ 0.78%
Net Income
15.8M
↓ 571.57%
Net Profit Margin
5.88%
↑ 7.14%
Q1 FY22Q/Q Change
Revenue
268.4M
↓ 0.01%
Net Income
15.3M
↓ 2.98%
Net Profit Margin
5.71%
↓ 0.17%
Q2 FY22Q/Q Change
Revenue
271.0M
↑ 1.0%
Net Income
3.2M
↓ 79.09%
Net Profit Margin
1.18%
↓ 4.53%
Q3 FY22Q/Q Change
Revenue
270.8M
↓ 0.07%
Net Income
-2.4M
↓ 175.84%
Net Profit Margin
-0.9%
↓ 2.08%
Q4 FY22Q/Q Change
Revenue
218.8M
↓ 19.2%
Net Income
6.4M
↓ 361.55%
Net Profit Margin
2.9%
↑ 3.8%
Q1 FY23Q/Q Change
Revenue
269.6M
↑ 23.18%
Net Income
11.7M
↑ 84.53%
Net Profit Margin
4.35%
↑ 1.45%
FY17Y/Y Change
Total Assets
1.1B
↑ 0.83%
Total Liabilities
393.1M
↓ 5.92%
FY18Y/Y Change
Total Assets
1.1B
↓ 1.42%
Total Liabilities
346.5M
↓ 11.86%
FY19Y/Y Change
Total Assets
1.3B
↑ 19.03%
Total Liabilities
507.6M
↑ 46.49%
FY20Y/Y Change
Total Assets
1.4B
↑ 5.87%
Total Liabilities
563.9M
↑ 11.09%
FY21Y/Y Change
Total Assets
1.4B
↑ 3.03%
Total Liabilities
494.9M
↓ 12.23%
FY22Y/Y Change
Total Assets
1.3B
↓ 9.12%
Total Liabilities
397.9M
↓ 19.6%
Q4 FY21Q/Q Change
Total Assets
1.4B
↓ 0.88%
Total Liabilities
494.9M
↓ 3.69%
Q1 FY22Q/Q Change
Total Assets
1.4B
↓ 3.31%
Total Liabilities
446.0M
↓ 9.9%
Q2 FY22Q/Q Change
Total Assets
1.4B
↓ 0.48%
Total Liabilities
447.9M
↑ 0.43%
Q3 FY22Q/Q Change
Total Assets
1.3B
↓ 4.07%
Total Liabilities
414.2M
↓ 7.51%
Q4 FY22Q/Q Change
Total Assets
1.3B
↓ 1.55%
Total Liabilities
397.9M
↓ 3.93%
Q1 FY23Q/Q Change
Total Assets
1.3B
↓ 0.79%
Total Liabilities
385.5M
↓ 3.14%
FY17Y/Y Change
Operating Cash Flow
94.5M
↑ 3.94%
Investing Cash Flow
-9.6M
↓ 88.27%
Financing Cash Flow
-49.1M
↑ 80.88%
FY18Y/Y Change
Operating Cash Flow
98.4M
↑ 4.2%
Investing Cash Flow
-33.7M
↑ 252.11%
Financing Cash Flow
-77.3M
↑ 57.46%
FY19Y/Y Change
Operating Cash Flow
100.1M
↑ 1.69%
Investing Cash Flow
-14.3M
↓ 57.62%
Financing Cash Flow
-79.7M
↑ 3.2%
FY20Y/Y Change
Operating Cash Flow
203.3M
↑ 103.05%
Investing Cash Flow
-63.9M
↑ 347.8%
Financing Cash Flow
-41.9M
↓ 47.47%
FY21Y/Y Change
Operating Cash Flow
62.4M
↓ 69.3%
Investing Cash Flow
-65.9M
↑ 3.15%
Financing Cash Flow
-35.3M
↓ 15.82%
Q4 FY21Q/Q Change
Operating Cash Flow
15.5M
↑ 130.0%
Investing Cash Flow
-13.1M
↓ 37.38%
Financing Cash Flow
-9.5M
↓ 2.39%
Q1 FY22Q/Q Change
Operating Cash Flow
-27.5M
↓ 276.88%
Investing Cash Flow
-5.9M
↓ 54.64%
Financing Cash Flow
-10.5M
↑ 10.06%
Q2 FY22Q/Q Change
Operating Cash Flow
26.2M
↓ 195.57%
Investing Cash Flow
-2.2M
↓ 62.11%
Financing Cash Flow
-8.3M
↓ 20.12%
Q3 FY22Q/Q Change
Operating Cash Flow
-2.0M
↓ 107.53%
Investing Cash Flow
-647.0K
↓ 71.15%
Financing Cash Flow
-16.7M
↑ 100.6%
Q1 FY23Q/Q Change
Operating Cash Flow
13.9M
↑ 16.11%
Investing Cash Flow
-1.4M
-
Financing Cash Flow
-12.6M
↑ 4.28%

Technicals Summary

Sell

Neutral

Buy

National Healthcare Corporation is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
National Healthcare Corporation
National Healthcare Corporation
5.04%
4.57%
-10.26%
-7.48%
-11.35%
Fresenius Medical Care Ag & Co. Kgaa
Fresenius Medical Care Ag & Co. Kgaa
-5.26%
48.75%
-14.48%
-47.63%
-55.2%
Hca Holdings, Inc.
Hca Holdings, Inc.
-2.42%
11.97%
38.16%
148.42%
155.35%
Universal Health Services Inc.
Universal Health Services Inc.
-3.64%
6.21%
18.85%
33.12%
16.82%
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
-1.8%
30.2%
4.64%
17.59%
35.18%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
National Healthcare Corporation
National Healthcare Corporation
50.59
50.59
0.0
0.0
0.02
0.01
0.04
57.25
Fresenius Medical Care Ag & Co. Kgaa
Fresenius Medical Care Ag & Co. Kgaa
10.76
10.76
1.06
2.22
4.45
0.03
0.03
23.56
Hca Holdings, Inc.
Hca Holdings, Inc.
17.26
17.26
1.37
18.16
0.21
0.11
0.01
-9.04
Universal Health Services Inc.
Universal Health Services Inc.
15.04
15.04
1.87
10.18
11.52
0.05
0.01
85.67
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
18.76
18.76
0.86
6.72
0.3
0.05
0.0
9.11
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
National Healthcare Corporation
National Healthcare Corporation
NA
$945.6M
-11.35%
50.59
1.75%
Fresenius Medical Care Ag & Co. Kgaa
Fresenius Medical Care Ag & Co. Kgaa
Hold
$12.6B
-55.2%
10.76
3.08%
Hca Holdings, Inc.
Hca Holdings, Inc.
Buy
$75.2B
155.35%
17.26
9.42%
Universal Health Services Inc.
Universal Health Services Inc.
Hold
$9.7B
16.82%
15.04
5.05%
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
Hold
$9.1B
35.18%
18.76
4.41%

Corporate Announcements

  • National Healthcare Corporation Dividends March,2023

    In the quarter ending March,2023. National Healthcare Corporation has declared dividend of $0.57

    Read More

Company Information

national healthcare corporation (nhc) has been providing the best in senior care for almost 50 years. at nhc, we believe that care should respect the individual, promote recovery, wellbeing and independence. we believe in celebrating life every day at our centers.in nhc communities, we currently operate 75 skilled nursing centers, 25 assisted living communities, a behavioral health hospital, five retirement communities and 35 homecare agencies. other services include memory care, senior care pharmacies, hospital, rehabilitation services and management and accounting services to third parties.nhc is recognized nationwide as an innovator in the delivery of quality long-term care. our goal has always been to provide a full range of extended care services, designed to maximize the wellbeing and independence of patients of all ages. we are dedicated to meeting patient needs through an interdisciplinary approach combining compassionate care with cost-effective health care services.

Organization
National Healthcare Corporation
Employees
12355
CEO
Dr. Stephen Fowler Flatt
Industry
Health Services

Discover More

FAQs